Stocks · News reference
Tevogen Bio shares are trading higher after the company announced continued progress across its strategic acquisition initiatives.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- May 28, 2026, 6:24 PM
- Checked
- May 28, 2026, 6:24 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Tevogen Bio Announces 2026 Annual Meeting of Stockholders
Tevogen Bio Holdings Inc. (NASDAQ: TVGN) announced its 2026 Annual Meeting of Stockholders scheduled for August 24, 2026, to be held virtually. The company has set July 23, 2026 as the record date for stockholders and the deadline for submitting stockholder proposals and director nominations. Tevogen continues to focus on its three complementary initiatives: Tevogen Bio (biotechnology), Tevogen.AI (artificial intelligence and technology), and Tevogen Healthcare Services, aimed at improving affordability and accessibility of life-saving medicines.
Read original at globenewswire-incTevogen Creates Healthcare Services Initiative Led By VP Of Strategic Initiatives William Keane On Interim Basis
Tevogen ("Tevogen Bio Holdings Inc." or "Company") (NASDAQ:TVGN) today announced the formation of its healthcare services initiative, a strategic business area intended to support the Company's evolution into a broader,
Read original at benzinga